BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3570630)

  • 1. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison.
    Austin RM; Norris HJ
    Int J Gynecol Pathol; 1987; 6(1):29-39. PubMed ID: 3570630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant Brenner tumor and transitional cell carcinoma of the ovary].
    Guo LN; Tang MY
    Zhonghua Bing Li Xue Za Zhi; 1990 Sep; 19(3):209-11. PubMed ID: 2279315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian Brenner tumors and transitional cell carcinoma: recent developments.
    Roth LM; Gersell DJ; Ulbright TM
    Int J Gynecol Pathol; 1993 Apr; 12(2):128-33. PubMed ID: 8463036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
    Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
    Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brenner and transitional cell tumours of the ovary. Report of three cases.
    Rantanen V; Grénman S; Kiilholma P; Salmi T; Klemi PJ
    Ann Chir Gynaecol Suppl; 1994; 208():28-32. PubMed ID: 8092766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
    Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
    Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitional cell carcinoma and other transitional cell tumors of the ovary.
    Roth LM; Gersell DJ; Ulbright TM
    Anat Pathol; 1996; 1():179-91. PubMed ID: 9390928
    [No Abstract]   [Full Text] [Related]  

  • 9. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
    Ali RH; Seidman JD; Luk M; Kalloger S; Gilks CB
    Int J Gynecol Pathol; 2012 Nov; 31(6):499-506. PubMed ID: 23018212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Brenner tumors. II. Malignant.
    Roth LM; Czernobilsky B
    Cancer; 1985 Aug; 56(3):592-601. PubMed ID: 4005816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benign and malignant Brenner tumor of the ovary: a clinicopathological and immunohistochemical study].
    Peng ZN
    Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):333-5. PubMed ID: 1284387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
    Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
    Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual presentation of benign cystic brenner tumor with exuberant psammomatous calcifications.
    Vemavarapu L; Alatassi H; Moghadamfalahi M
    Int J Surg Pathol; 2011 Feb; 19(1):120-2. PubMed ID: 21087980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis.
    Eichhorn JH; Young RH
    Am J Surg Pathol; 2004 Apr; 28(4):453-63. PubMed ID: 15087664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas.
    Shetty S; Habeeb O; Rivera C; Astbury C; Przybycin C; Joehlin-Price AS
    Hum Pathol; 2021 Nov; 117():42-50. PubMed ID: 34391746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian Brenner tumors. I. Metaplastic, proliferating, and of low malignant potential.
    Roth LM; Dallenbach-Hellweg G; Czernobilsky B
    Cancer; 1985 Aug; 56(3):582-91. PubMed ID: 4005815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic features observation of ovarian transitional cell tumors].
    Wang L; Dong Y; Li Q; Li H; Sun X; Zhou X; Li X
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):118-22. PubMed ID: 25916643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
    Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
    Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transitional cell carcinoma of the ovary. Morphological and clinical features].
    Kommoss F; Kommoss S; Eichhorn J; Schmidt D
    Pathologe; 2007 May; 28(3):209-14. PubMed ID: 17447068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitional cell carcinoma of the endometrium associated with a benign ovarian Brenner tumor: a case report.
    Labonté S; Têtu B; Boucher D; Larue H
    Hum Pathol; 2001 Feb; 32(2):230-2. PubMed ID: 11230712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.